Edition:
United Kingdom

ANI Pharmaceuticals Inc (ANIP.OQ)

ANIP.OQ on NASDAQ Stock Exchange Global Market

54.51USD
11 Dec 2018
Change (% chg)

$-0.41 (-0.75%)
Prev Close
$54.92
Open
$55.46
Day's High
$55.46
Day's Low
$52.92
Volume
15,724
Avg. Vol
28,484
52-wk High
$73.41
52-wk Low
$48.51

Latest Key Developments (Source: Significant Developments)

Ani Pharmaceuticals To Repurchase $25 Mln Aggregate Principal Amount Of Notes
Friday, 7 Dec 2018 

Dec 7 (Reuters) - ANI Pharmaceuticals Inc ::ANI PHARMACEUTICALS ENTERS INTO SEPARATE PRIVATELY NEGOTIATED AGREEMENTS WITH CERTAIN HOLDERS OF ITS CONVERTIBLE NOTES.ANI PHARMACEUTICALS-ENTERED INTO SEPARATE, PRIVATELY NEGOTIATED AGREEMENTS WITH CERTAIN HOLDERS OF OUTSTANDING 3.00% CONVERTIBLE SENIOR NOTES DUE 2019.ANI PHARMACEUTICALS INC - AGREED TO REPURCHASE $25.0 MILLION AGGREGATE PRINCIPAL AMOUNT OF NOTES FOR A TOTAL OF $26.1 MILLION IN CASH.ANI PHARMACEUTICALS INC - ANI HAS ALSO ENTERED INTO AN AGREEMENT WITH DEALER PARTY TO CERTAIN CONVERTIBLE NOTE HEDGE TRANSACTIONS.ANI PHARMACEUTICALS INC - ALSO ENTERED INTO AGREEMENTS WITH SUCH DEALER COUNTERPARTY TO UNWIND CERTAIN WARRANT TRANSACTIONS.  Full Article

ANI Pharmaceuticals Announces Approval Of Morphine Sulfate Oral Solution
Wednesday, 18 Apr 2018 

April 18 (Reuters) - ANI Pharmaceuticals Inc ::ANI PHARMACEUTICALS ANNOUNCES APPROVAL OF MORPHINE SULFATE ORAL SOLUTION.ANI PHARMACEUTICALS INC - RECEIVED APPROVAL FROM U.S. FDA OF ITS ANDA FOR MORPHINE SULFATE ORAL SOLUTION 10MG/5ML, 20MG/5ML AND 100MG/5ML.  Full Article

Ani Pharmaceuticals Enters Five-Year $125 Mln Senior Secured Credit Facility With Citizens Bank
Friday, 29 Dec 2017 

Dec 29 (Reuters) - Ani Pharmaceuticals Inc ::ANI PHARMACEUTICALS ENTERS FIVE-YEAR $125 MILLION SENIOR SECURED CREDIT FACILITY WITH CITIZENS BANK.ANI PHARMACEUTICALS SAYS FACILITY ALSO INCLUDES A $50 MILLION SENIOR SECURED REVOLVING CREDIT FACILITY WHICH REMAINS UN-DRAWN.ANI PHARMA SAYS TERM LOAN ALSO USED TO REFINANCE EXISTING INDEBTEDNESS OF $25 MILLION.  Full Article

Ani Pharmaceuticals Acquires Four NDAs From AstraZeneca For $46.5 Mln
Friday, 29 Dec 2017 

Dec 29 (Reuters) - Ani Pharmaceuticals Inc ::ANI PHARMACEUTICALS ACQUIRES FOUR NDAS FROM ASTRAZENECA FOR $46.5 MILLION.ANI PHARMACEUTICALS INC - ACQUISITIONS WERE FUNDED THROUGH A COMBINATION OF CASH AND DEBT.ANI PHARMACEUTICALS SAYS ADDITION OF ASSETS WILL BE MATERIAL TO REVENUE AND EBITDA IN 2018.  Full Article

ANI Pharmaceuticals Q3 gaap earnings per share $0.40
Thursday, 2 Nov 2017 

Nov 2 (Reuters) - ANI Pharmaceuticals Inc :ANI Pharmaceuticals reports record third quarter and year-to-date 2017 results and narrows full year guidance.Q3 adjusted Non-GAAP earnings per share $1.11.Q3 GAAP earnings per share $0.40.Q3 revenue $48.2 million versus I/B/E/S view $48.1 million.Q3 earnings per share view $0.99 -- Thomson Reuters I/B/E/S.ANI Pharmaceuticals Inc sees ‍for full year 2017 net revenues $181 million to $183 million​.ANI Pharmaceuticals Inc sees ‍for full year 2017 adjusted Non-GAAP diluted earnings per share $3.83 to $4.00​.Q3 earnings per share view $0.99, revenue view $48.1 million -- Thomson Reuters I/B/E/S.FY2017 earnings per share view $3.84, revenue view $182.1 million -- Thomson Reuters I/B/E/S.ANI Pharmaceuticals Inc - ‍ANI intends to request a meeting with fda in Q4 of 2017 to present its regulatory filing plan​.  Full Article

Ani Pharma acquires Inderal XL and Innopran XL
Friday, 24 Feb 2017 

Ani Pharmaceuticals Inc : Ani pharmaceuticals acquires inderal® xl and innopran xl® . Ani pharmaceuticals inc - acquisitions were funded through a combination of cash and debt . Ani pharma - has begun selling inderal xl 80mg, 120mg sustained release capsules, innopran xl 80mg, 120mg sustained release capsules under current labels . Ani pharma - will transition inderal xl and innopran xl to ani label at a future date . Ani pharmaceuticals inc - acquired inderal xl from cranford pharmaceuticals, llc and innopran xl from holmdel pharmaceuticals lp .Ani pharmaceuticals inc- acquired inderal xl from cranford pharmaceuticals, llc and innopran xlfrom holmdel pharmaceuticals lp.  Full Article